International Pharma Talks

ELS Solutions Group
  • 0.0 (0)
  • BUSINESS

Welcome to the International Pharma Talks, powered by ELS Solutions Group, a podcast hosted by Dr. Diogo Sousa-Martins, Ph.D., MBA. This podcast will dive deep into the world of pharma & healthcare international business where you will learn strategies and action plans to help you navigate through your internationalization program and achieve the best results. If you wish to develop your international program in pharma, healthcare or medtech areas or to register or distribute your products in another market, please consult https://www.els-solutions.com/en/.

  1. Impacto na Falsificação de Bebidas e Alimentos: Como Proteger Consumidores e Marcas

    JAN 8

    Impacto na Falsificação de Bebidas e Alimentos: Como Proteger Consumidores e Marcas

    Como a Falsificação de Bebidas e Alimentos Afeta a Saúde Pública, a Conformidade Regulatória e a Sustentabilidade das Marcas? A falsificação de bebidas e alimentos deixou de ser um problema pontual para se tornar um risco sistêmico, com impactos diretos na saúde pública, na confiança do consumidor e na credibilidade das empresas. Em cadeias de suprimento globais cada vez mais fragmentadas, falhas nos controles regulatórios, na rastreabilidade e na logística criam oportunidades para a inserção de produtos adulterados, ilegais ou de origem desconhecida no mercado formal. Neste episódio do International Pharma Talks, Eliane Miyazaki, Senior Business Development Manager do ELS Group, analisa de forma aprofundada como a falsificação de alimentos e bebidas está diretamente relacionada a deficiências nos sistemas de controle e fiscalização, e como proteger consumidores e marcas. Ao explorar o papel da conformidade regulatória e dos sistemas de qualidade ao longo de toda a cadeia de suprimentos, o episódio demonstra como a ausência de controles eficazes pode resultar em apreensões, recalls, sanções administrativas e danos reputacionais de longo prazo, enquanto estruturas robustas de governança reduzem riscos e fortalecem a confiança do mercado. Você vai compreender melhor: Como a falsificação de bebidas e alimentos impacta diretamente a saúde do consumidor e a segurança sanitária; O papel das autorizações, certificações e registros oficiais na proteção da cadeia legal de fornecimento; Como falhas de rastreabilidade e controle documental favorecem a circulação de produtos adulterados; Por que sistemas de qualidade, monitoramento contínuo e due diligence regulatória são fundamentais para a proteção das marcas; Como empresas, inclusive de menor porte, podem estruturar modelos eficientes de prevenção à falsificação sem comprometer sua competitividade. Em um contexto no qual produtos falsificados podem causar intoxicações, agravos à saúde e perda de vidas, além de prejuízos econômicos expressivos, a negligência deixa de ser apenas um risco operacional e passa a representar uma ameaça institucional. A prevenção à falsificação exige cadeias de suprimento transparentes, rastreáveis e plenamente alinhadas à legislação sanitária vigente. Acompanhe este episódio para entender como a adoção de estratégias regulatórias sólidas, aliadas a controles logísticos e sistemas de qualidade eficazes, contribui para a proteção do consumidor, a preservação das marcas e a integridade do mercado de bebidas e alimentos. Saiba mais em: els-solutions.com Este episódio foi gravado em 2026. Parte das informações discutidas pode ter sido atualizada posteriormente. O podcast foi elaborado com base em diversas fontes bibliográficas. As opiniões expressas refletem a experiência profissional dos membros da ELS e o conteúdo das referências consultadas.

    18 min

  2. 09/25/2025

    How Efficiency in Import and Distribution Logistics Drives Global Success

    How Efficiency in Import and Distribution Logistics Drives Global Success? Efficient importation and distribution are no longer operational afterthoughts, they are strategic imperatives for pharmaceutical and MedTech companies seeking global expansion. But what are the hidden risks, and how can companies truly optimize their logistics while remaining compliant? In this episode of International Pharma Talks, Dr. Diogo Sousa-Martins, Founder and President of ELS Group, explores how mastering the complexities of global import and distribution logistics is key to regulatory compliance, operational efficiency, and patient safety. From navigating regulatory mazes to mitigating supply chain risks, we’ll break down what separates companies that scale globally from those that stumble at the border. You’ll learn more about: How regulatory compliance shapes logistics strategies across multiple marketsThe key certifications that open doors to international tradeCommon challenges in customs clearance and how to overcome themHow to prevent product recalls, supply interruptions, and reputational damageWhy robust quality systems and traceability are essential in combatting counterfeitsHow smaller companies can scale efficiently through strategic logistics planning In a market where a single delay can cost millions, or put lives at risk, companies cannot afford inefficiency. Supply chains must be proactive, compliant, and resilient. Tune in now to understand how optimizing your import and distribution operations can drive faster market entry, reduce costs, and safeguard both your product and your patients. Learn more at els-solutions.com This episode was recorded in 2025. Some of the data discussed may have changed since then. This podcast has been prepared using various bibliographic sources. The opinions expressed reflect the professional experiences of ELS members and referenced material.

    12 min

  3. 07/18/2025

    The Integration of Artificial Intelligence in Pharmacovigilance. Transforming Drug Safety

    Artificial Intelligence is Reshaping Pharmacovigilance – But Are You Ready? With over 1.5 million adverse drug reactions reported annually in the EU alone, the pressure on pharmacovigilance systems has never been greater. Could artificial intelligence (AI) be the answer? In this episode of International Pharma Talks, Dr. Diogo Sousa-Martins, Founder and President of ELS Group, discusses how AI is transforming the landscape of drug safety, and what pharmaceutical companies must do to stay ahead. From automation and real-time signal detection to regulatory hurdles and ethical challenges, we break down how AI is redefining the future of pharmacovigilance and what that means for compliance, patient safety, and innovation. You’ll learn more about: How AI enhances adverse event detection across large, unstructured data sources Compliance requirements under EMA, FDA, and ISO standards Why early-stage integration of AI is a strategic (not optional) investment How companies can adopt scalable, cost-effective AI solutions without compromising compliance The integration of AI into pharmacovigilance isn’t a distant possibility, it’s an urgent priority. But real transformation requires more than just algorithms. It demands strategic planning, regulatory alignment, and expert guidance. Tune in now to understand how your company can use AI to enhance pharmacovigilance performance, reduce risk, and strengthen patient trust. Learn more at els-solutions.com/This episode was recorded in 2025. Some of the data discussed may have changed since then. This podcast has been prepared using various bibliographic sources. The opinions expressed reflect the professional experiences of ELS members and referenced material.

    10 min
  4. Exploring the market and regulatory opportunities of medicinal cannabis in Brazil

    03/07/2025

    Exploring the market and regulatory opportunities of medicinal cannabis in Brazil

    Brazil’s medicinal cannabis market is evolving rapidly, with more patients, new regulatory pathways, and a growing industry presence. But how accessible are these treatments, and what are the biggest challenges companies face? In this episode of International Pharma Talks, Dr. Diogo Sousa-Martins explores the business and regulatory landscape of medicinal cannabis in Brazil. From market trends to future policy changes, we’ll break down what’s shaping this fast-moving sector. You’ll learn more about: The surge in patient numbers and what it means for market growthRegulatory frameworks for cannabis-based treatments and their challengesWhy official drug registrations remain rare despite existing pathwaysThe impact of Anvisa’s upcoming regulatory agenda on the industry With Brazil poised to become a key player in Latin America's cannabis market, understanding these developments is crucial. Tune in now to stay ahead of the curve. Learn more at els-solutions.com. "This episode was recorded in 2024. As such, some of the data discussed may have changed. This podcast has been prepared from different bibliographic sources. The opinions and comments conveyed therein are based on previous corporate experiences of ELS members, in addition to the references listed."

    13 min

  5. 02/27/2025

    Changes and Evolution in the Pharmaceutical Market

    The pharmaceutical market is constantly evolving,shaped by innovation, shifting demands, and regulatory developments. In this episode of International Pharma Talks, our host, Dr. Diogo Sousa-Martins explores how the industry is changing and what these transformations mean forthe future. Tune in to discover:  How technology is reshaping drug development andhealthcare The impact of regulatory changes on marketstrategies The shift towards personalized medicine andpatient-centered care The role of emerging markets in the globalpharmaceutical landscape  Understanding these changes is crucial for staying ahead in the industry. Learn more about it at els-solutions.com   * "This podcast has been prepared from different bibliographic sources. As such, the opinion and comments conveyed therein are based on previous corporate experiences of ELS members, in addition to the referenceslisted."

    8 min

  6. 01/31/2025

    The Future of Pharma: Key trends to watch in 2025

    What does the future look like for the pharma industry in 2025? Join Dr. Diogo Sousa-Martins in our latest episode of International Pharma Talks, where he explores the key trends shaping the pharmaceutical landscape this year. With rapid advancements in AI, regulatory changes, and the growing importance of personalized medicine, staying ahead has never been more critical. In this episode, you’ll learn more about: - The rise of AI in drug discovery and its impact on R&D efficiency - Global market dynamics and the expansion of emerging pharma markets - The growing role of personalized medicine in patient care - Regulatory changes influencing drug approvals and market success and many more.. As the industry evolves, understanding these shifts will be essential for success. Tune in now to gain valuable insights and prepare for what’s ahead. Learn more about it at els-solutions.com * "This podcast has been prepared from different bibliographic sources. As such, the opinion and comments conveyed therein are based on previous corporate experiences of ELS members, in addition to the references listed."

    17 min
  7. The expansion of the Cannabis market in Europe

    01/17/2025

    The expansion of the Cannabis market in Europe

    In the 37th episode, our host, Dr. Diogo Sousa-Martins delves into the dynamic and rapidly evolving cannabis market in Europe, analyzing how the regulatory frameworks, market trends, and societal implications works in this controversial yet very promising industry. From the rise of medical cannabis markets in Germany, Poland, the Czech Republic, and Switzerland to recent advancements in recreational cannabis legalization in European countries, this episode sheds light on the shifting landscape of cannabis policies across the continent. Some of the topics this episode will cover: - The role of cannabis in medicinal and recreational markets. - Challenges faced by companies, including regulatory inconsistencies, misinformation, and the need for clinical research. - Insights into the economic potential of cannabis markets, with projections and data on emerging leaders in Europe. Tune in to discover how cannabis regulation and market expansion are shaping the future of medicine, business, and society. For more information regarding regulatory and market expansion issues, visit ⁠els-solutions.com

    12 min

  8. 04/10/2024

    Challenges of the new Medical Device Regulation in Europe

    In episode number 36 of the Podcast "International Pharma Talks by ELS Solutions" our host, Dr, Diogo Sousa Martins, PhD, MBA, will focus on "Challenges of the new Medical Device Regulation in Europe".

    15 min
See All (43)

About

Welcome to the International Pharma Talks, powered by ELS Solutions Group, a podcast hosted by Dr. Diogo Sousa-Martins, Ph.D., MBA. This podcast will dive deep into the world of pharma & healthcare international business where you will learn strategies and action plans to help you navigate through your internationalization program and achieve the best results. If you wish to develop your international program in pharma, healthcare or medtech areas or to register or distribute your products in another market, please consult https://www.els-solutions.com/en/.

Information

  • Creator
    ELS Solutions Group
  • Years Active
    2020 - 2026
  • Episodes
    43
  • Rating
    Clean
  • Copyright
    © ELS Solutions Group
  • Show Website
    International Pharma Talks